Skip to main content
. 2020 Nov 11;11:581711. doi: 10.3389/fmicb.2020.581711

TABLE 2.

Distribution of β-lactamase, quinolone, aminoglycoside, and cotrimoxazole resistance genes among ESBL-producing E. coli and K. pneumoniae.

GPED (199)
NICU (38)
PICU (90)
E. coli (168) K. pneumoniae (31) E. coli (19) K. pneumoniae (19) E. coli (67) K. pneumoniae (23)
No (%)
ESBL genes
blaCTX–M–15 142 (84.5) 31 (100) 19 (100) 18 (94.7) 56 (83.5) 21 (91.3)
blaCTX–M–14 8 (4.7) — — — — 1 (4.3)
blaSHV–106 — 6 (19.4) — 2 (10.5) — 1 (4.3)
blaTEM–104 5 (3) — — — 3 (4.5) —
blaCTX–M–102 5 (3) — — — 3 (4.5) —
blaCTX–M–159 5 (3) — — — 2 (3) —
blaCTX–M–3 2 (1.2) — — — 1 (1.5) —
blaCTX–M–27 1 0.6) — — — 2 (3) —
blaSHV–27 — 4 (12.9) — 2 (10.5) — 2 (8.6)
blaCTX–M–1 1 (0.6) — — — 2 (3) 1 (4.3)
Other βL genes
blaTEM–1B 60 (35.7) 17 (54.8) 14 (73.7) 12 (63.2) 24 (35.8) 7 (34.8)
blaOXA–1 23 (13.7) 17 (54.8) 5 (26.3) 8 (42.1) 7 (10.4) 4 (17.4)
blaNDM 1/5 5 (3) 4 (12.9) — — 2 (3) 1 (4.3)
blaDHA 6 (3.6) 2 (6.5) — — — 1 (4)
blaTEM–33/35 6 (3.6) — — — — 1 (4.3)
blaOXA–48 4 (2.4) 1 (3.2) — — 1 (1.5) —
blaCMY 2 (1.2) — — — 3 (4.5) —
PMQR-G
aac(6′)-Ib-cr 21 (12.5) 14 (45.1) 3 (15.8) 7 (36.7) 8 (11.9) 4 (17.4)
oqxAB — — — — 1 (1.5) —
qepA1 — — 2 (10.5) — — —
qnr A/B/E/S 64 (38.1) 21 (67.8) 7 (36.8) 11 (57.9) 28 (41.8) 17 (73.9)
AME-G
aac(3)-II* 28 (16.7) 11 (35.5) 5 (26.3) 8 (42.1) 11 (16.4) 1 (4.3)
aadA1 18 (10.7) 4 (12.9) — 2 (10.5) 10 (14.9) 1 (4.3)
aadA2 6 (3.6) 6 (19.4) 6 (31.6) 2 (10.5) 5 (7.7) 5 (21.7)
aadA5 51 (30.4) 2 (6.5) 1 (5.3) — 22 (32.3) 1 (4.3)
aph(3′)-Ia 13 (7.7) 4 (12.9) — 2 (10.5) 2 (3) 4 (17.4)
aph(3″)-Ib 72 (42.8) 21 (67.8) 6 (31.6) 14 (73.7) 32 (47.8) 15 (65.2)
aph(6)-Id 69 (41.1) 21 (67.8) 6 (31.6) 14 (73.7) 33 (49.3) 16 (65.2)
SXT-RG
dfrA/B 114 (67.9) 25 (80.7) 13 (68.4) 12 (63.2) 46 (68.7) 14 (60.9)
sul1-3 112 (66.7) 24 (77.4) 14 (73.7) 15 (78.9) 46 (68.7) 14 (60.9)

PMQR-G, plasmid-mediated quinolone resistance genes; AME-G, aminoglycoside-modifying enzyme genes; SXT-RG, cotrimoxazole resistance genes.*Comprised aac(3)-IIa and aac(3)-IId, aac(3)-IVa, and aac(3)-Via.